Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Share News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 380.00
Bid: 374.00
Ask: 386.00
Change: 0.00 (0.00%)
Spread: 12.00 (3.209%)
Open: 380.00
High: 380.00
Low: 380.00
Prev. Close: 380.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MaxCyte signs strategic platform licence with Catamaran Bio

Wed, 04th Jan 2023 07:45

(Sharecast News) - Commercial cell engineering company MaxCyte announced the signing of a strategic platform licence (SPL) with Catamaran Bio on Wednesday.

The AIM-traded firm described Catamaran Bio as a biotechnology company developing novel, off-the-shelf chimeric antigen receptor (CAR)-NK cell therapies to treat a broad range of cancers, with a primary focus on solid tumours.

Under the terms of the agreement, Catamaran would obtain non-exclusive clinical and commercial rights to use MaxCyte's 'Flow Electroporation' technology and 'ExPERT' platform.

In return, MaxCyte would receive platform licensing fees and program-related revenue.

"The ability to leverage synthetic biology to engineer cell therapies will help drive innovative solutions for solid tumour cancer treatment," said president and chief executive officer Doug Doerfler.

"At MaxCyte, we are passionate about driving the discovery, development and manufacturing of next-generation, cell-based medicines to tackle complex diseases and cancer.

"We are excited to support Catamaran with the advancement of their pipeline of differentiated CAR-NK cell therapies into and through the clinic."

At 1049 GMT, shares in MaxCyte were up 1.26% at 443p.

Reporting by Josh White for Sharecast.com.

More News
3 Feb 2021 21:38

IN BRIEF: GBP40 Million MaxCyte Subscription Ahead Of Dual Listing

IN BRIEF: GBP40 Million MaxCyte Subscription Ahead Of Dual Listing

Read more
20 Jan 2021 17:40

LONDON TRADING UPDATES: Alliance Pharma 2020 Revenue Slips By 5%

LONDON TRADING UPDATES: Alliance Pharma 2020 Revenue Slips By 5%

Read more
11 Jan 2021 14:51

UK TRADING UPDATE SUMMARY: Science Group To Beat Forecasts For 2020

UK TRADING UPDATE SUMMARY: Science Group To Beat Forecasts For 2020

Read more
23 Dec 2020 10:36

Maxcyte Core Life Sciences Business Results To Beat Expectations

Maxcyte Core Life Sciences Business Results To Beat Expectations

Read more
23 Oct 2020 16:04

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
13 Oct 2020 14:06

UK EXECUTIVE CHANGE SUMMARY: Danakali Hires Potash Mining Vet As COO

UK EXECUTIVE CHANGE SUMMARY: Danakali Hires Potash Mining Vet As COO

Read more
21 Sep 2020 16:24

IN BRIEF: MaxCyte Interim Revenue Jumps And Loss Narrows

IN BRIEF: MaxCyte Interim Revenue Jumps And Loss Narrows

Read more
14 Sep 2020 15:44

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
9 Sep 2020 14:28

MaxCyte Hires Murphy As Finance Chief; Holtz Becomes Accounting Boss

MaxCyte Hires Murphy As Finance Chief; Holtz Becomes Accounting Boss

Read more
9 Sep 2020 09:35

MaxCyte appoints Amanda Murphy as CFO

(Sharecast News) - Life sciences company MaxCyte named Amanda Murphy as its chief financial officer on Wednesday, succeeding long-time CFO Ron Holtz.

Read more
18 Aug 2020 20:04

IN BRIEF: MaxCyte Says CARMA's Phase 1 MCY-M11 Trial Expanded

IN BRIEF: MaxCyte Says CARMA's Phase 1 MCY-M11 Trial Expanded

Read more
15 Jul 2020 13:31

MaxCyte Sees Higher Interim Revenue, Confident On Long-Term Prospects

MaxCyte Sees Higher Interim Revenue, Confident On Long-Term Prospects

Read more
8 Jul 2020 15:51

IN BRIEF: MaxCyte Signs APN401 Licensing Deal With Apeiron Biologics

IN BRIEF: MaxCyte Signs APN401 Licensing Deal With Apeiron Biologics

Read more
7 May 2020 17:30

UK TRADING UPDATE SUMMARY: Filta Launches Covid-19 Sanitising Service

UK TRADING UPDATE SUMMARY: Filta Launches Covid-19 Sanitising Service

Read more
1 May 2020 08:54

MaxCyte Raises GBP25 Million To Fund Investments Ahead Of US IPO

MaxCyte Raises GBP25 Million To Fund Investments Ahead Of US IPO

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.